Financhill
Back

Summit Therapeutics Quote, Financials, Valuation and Earnings

Summit Therapeutics Price Quote

$19.72
+0.80 (+4.23%)
(Updated: October 8, 2024 at 6:55 PM ET)

Summit Therapeutics Key Stats

Sell
44
Summit Therapeutics (SMMT) is a Sell

Day range:
$18.71 - $20.18
52-week range:
$1.64 - $33.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13,897.66
P/B ratio:
71.28%

Volume:
2.4M
Avg. volume:
8.4M
1-year change:
975%
Market cap:
$13.9B
Revenue:
$0
EPS:
$-0.19

How Much Does Summit Therapeutics Make?

Data Unavailable

Is Summit Therapeutics Growing As A Company?

Data Unavailable

Summit Therapeutics Stock Price Performance

What Is Summit Therapeutics 52-Week High & Low?

Summit Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Summit Therapeutics?

Is Summit Therapeutics Cash Flow Positive?

  • What Is SMMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$97.5M
  • What Is Summit Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $207.2M
  • What Is Summit Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$123.1M

Summit Therapeutics Return On Invested Capital

Data Unavailable

Summit Therapeutics Earnings Date & Stock Price

Summit Therapeutics Competitors

Summit Therapeutics Dividend Yield

Summit Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -44.76%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 35.88
Upside from Last Price: 89.65%

Major Shareholders

  • How many SMMT shares are owned by institutional investors?
    101M SMMT shares are owned by institutional investors
  • How many SMMT shares are owned by insiders?
    142.7M SMMT shares are owned by insiders